Catalyst Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio15.1925.1023.3017.684.62
Forward P/E15.3814.1314.9813.978.97
P/S Ratio5.064.509.044.962.91
P/B Ratio3.424.626.443.382.04
Price/Tangible Book4.369.257.223.382.04
Price/FCF10.4018.2611.767.69
Price/OCF10.3812.4816.6811.567.69
Enterprise Value Ratios
EV/Revenue4.174.217.863.751.84
EV/EBITDA8.8013.9916.3310.035.29
EV/EBIT10.5119.2916.5310.075.31
EV/FCF8.5715.888.894.87
Profitability & Returns
Return on Equity (ROE)0.29%0.21%0.33%0.21%0.58%
Return on Assets (ROA)0.18%0.13%0.21%0.15%0.17%
Return on Invested Capital (ROIC)0.63%0.51%6.29%1.60%3.53%
Return on Capital Employed (ROCE)0.27%0.22%0.32%0.25%0.24%
Leverage & Solvency Ratios
Debt/Equity0.000.010.010.020.00
Debt/EBITDA0.010.030.040.080.00
Debt/FCF0.010.040.070.00
Liquidity Ratios
Current Ratio5.172.885.577.767.00
Quick Ratio4.832.525.377.326.45
Efficiency Ratios
Asset Turnover0.740.940.700.660.78
Inventory Turnover4.6312.937.386.2010.15
Yield & Distribution Ratios
Earnings Yield0.07%0.04%0.04%0.06%0.22%
FCF Yield0.10%-0.03%0.05%0.09%0.13%
Buyback Yield-0.10%-0.02%-0.03%-0.01%0.00%